Molina Healthcare Surges 15% After Q1 Earnings Beat Estimates
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy MOH?
Source: seekingalpha
- Earnings Beat: Molina Healthcare reported Q1 adjusted EPS of $2.35, exceeding analyst expectations by $0.41, indicating strong profitability despite overall revenue of $10.79 billion missing consensus, reflecting intensified market competition.
- Revenue Decline Reasons: While the company affirmed its full-year premium revenue guidance of approximately $42 billion, Q1 premium revenue of $10.2 billion represented a 4% year-over-year decrease, primarily due to reduced Medicaid membership and the expiration of its Virginia Medicaid contract, impacting market share.
- Consolidated MCR: Molina reported a consolidated medical care ratio (MCR) of 91.1% for Q1, with a Medicaid MCR of 92.0%, indicating challenges in managing medical costs that could affect future profitability.
- Full-Year Guidance Affirmation: Despite revenue pressures, Molina reaffirmed its full-year guidance of at least $5.00 adjusted EPS, demonstrating confidence in future performance and aiming to restore market competitiveness through optimized product and pricing strategies.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MOH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MOH
Wall Street analysts forecast MOH stock price to rise
14 Analyst Rating
3 Buy
9 Hold
2 Sell
Hold
Current: 153.000
Low
155.00
Averages
180.85
High
250.00
Current: 153.000
Low
155.00
Averages
180.85
High
250.00
About MOH
Molina Healthcare, Inc. is a provider of managed healthcare services under the Medicaid and Medicare programs, and through the state insurance marketplaces. The Company operates through four segments: Medicaid, Medicare, Marketplace and Other. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. Medicaid provides healthcare and long-term services and support to low-income Americans. Medicare is a federal program that provides eligible persons aged 65 and over, and some disabled persons, with a variety of hospital, medical insurance, and prescription drug benefits. The Marketplace insurance exchanges allow individuals and small groups to purchase federally subsidized health insurance. It arranges healthcare services for its members through contracts with a network of providers, including independent physicians and physician groups, hospitals, ancillary providers, and pharmacies.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Medical Cost Performance Beat: Molina Healthcare's Q1 medical care ratio reached 91.1%, significantly exceeding expectations and helping to stabilize investor concerns about rising healthcare costs, demonstrating the company's effectiveness in managing medical expenses.
- Earnings Outlook Improvement: Burry anticipates Molina could return to over $20 EPS, although the $25 target may take 2-3 years to achieve, indicating a growing confidence in the company's long-term profitability.
- Investor Sentiment Shift: Following Molina's earnings report, retail sentiment surged from 'bullish' to 'extremely bullish', with a 550% increase in message volume within 24 hours, reflecting optimism about the company's future prospects.
- Policy Tailwind Impact: Recent confirmation by U.S. regulators of a 2.48% increase in 2027 Medicare Advantage payment rates is expected to add over $13 billion in funding to private Medicare Advantage plans, further supporting Molina's growth potential.
See More
- Earnings Beat: Molina Healthcare reported Q1 adjusted EPS of $2.35, exceeding analyst expectations by $0.41, indicating strong profitability despite overall revenue of $10.79 billion missing consensus, reflecting intensified market competition.
- Revenue Decline Reasons: While the company affirmed its full-year premium revenue guidance of approximately $42 billion, Q1 premium revenue of $10.2 billion represented a 4% year-over-year decrease, primarily due to reduced Medicaid membership and the expiration of its Virginia Medicaid contract, impacting market share.
- Consolidated MCR: Molina reported a consolidated medical care ratio (MCR) of 91.1% for Q1, with a Medicaid MCR of 92.0%, indicating challenges in managing medical costs that could affect future profitability.
- Full-Year Guidance Affirmation: Despite revenue pressures, Molina reaffirmed its full-year guidance of at least $5.00 adjusted EPS, demonstrating confidence in future performance and aiming to restore market competitiveness through optimized product and pricing strategies.
See More
- Netflix Buyback Plan: Netflix authorized an additional $25 billion share buyback, leading to a stock price increase of over 1%, aimed at boosting shareholder confidence and enhancing long-term company value.
- Helix Merger Announcement: Helix Energy Solutions agreed to merge with Hornbeck Offshore Services in an all-stock deal, resulting in a more than 3% rise in stock price, with the merger expected to close in the second half of 2026, enhancing competitive positioning in the offshore services market.
- Honeywell Mixed Earnings: Honeywell reported Q1 adjusted earnings of $2.45 per share, beating expectations, but revenue of $9.1 billion fell short of forecasts, causing a 5.6% drop in stock price, reflecting market concerns over its future guidance.
- Mobileye Strong Performance: Mobileye reported Q1 adjusted earnings of 12 cents per share on revenue of $558 million, both exceeding analyst expectations, resulting in an 11% stock price increase, indicating robust growth potential in the autonomous driving sector.
See More
- Market Rally and Trump: Burry noted that Trump has a knack for diverting attention when market sentiment turns bearish, although he emphasized that corporate earnings will be a more significant market driver.
- New Market Highs: U.S. stock markets reached record highs with the S&P 500 closing at 7,137.90 after Trump extended a ceasefire with Iran, indicating the market's sensitivity to political events.
- Focus on Earnings: Burry urged investors to pay attention to corporate earnings, asserting that the current quarter's results are less important than future outlooks, especially as major companies like Tesla and Boeing report earnings.
- Volatility Expectations: While Burry believes a “needle top” crash is unlikely, he warned of potential volatility in the coming months due to elections and geopolitical issues, advising investors to remain vigilant.
See More
- IBM Earnings Miss: IBM reported Q1 earnings of $1.91 per share, beating the $1.81 forecast, yet failed to raise its full-year guidance, resulting in a 6% drop in shares, indicating market concerns over future growth prospects.
- Tesla's Mixed Results: Tesla's Q1 adjusted earnings were 41 cents per share, surpassing the 37 cents expected by analysts, but its revenue of $22.39 billion fell short of the $22.64 billion consensus, reflecting cautious market sentiment regarding sales growth.
- Texas Instruments Strong Outlook: Texas Instruments forecasts current-quarter earnings between $1.77 and $2.05 per share, significantly above the $1.57 consensus, leading to a 10% increase in shares, showcasing robust demand in the semiconductor sector.
- United Rentals Sales Forecast Boost: United Rentals raised its full-year sales forecast to a range of $16.9 billion to $17.4 billion, with shares jumping over 15%, indicating strong market momentum heading into the busy season.
See More
- Industry Confidence Boost: Molina Healthcare's shares rose 1.9% in the afternoon session as UnitedHealth Group reported stronger-than-expected first-quarter profits, reflecting a surge in investor confidence across the healthcare insurance sector.
- Volatility Insights: The stock has experienced 19 moves greater than 5% over the past year, indicating that today's increase is seen as significant by the market, although it does not fundamentally alter perceptions of Molina's business.
- Profitability Challenges: Molina's adjusted earnings of $1.84 per share fell 52.7% short of analyst expectations of $3.89, prompting the company to lower its 2025 adjusted earnings guidance by 26.3%, highlighting ongoing profitability issues.
- Long-term Investment Returns: Molina's stock is down 15.3% year-to-date, trading at $151.08, which is 54.5% below its 52-week high of $332, indicating that investors who bought $1,000 worth of shares five years ago would now see only $593.78.
See More











